License Fees Help Exact Sciences Cut Q4 Net Loss | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences today reported that it had cut its fourth-quarter net loss 14 percent, as it took in licensing fees that were more than three times greater than those received in Q4 2008.

The Madison, Wis.-based molecular diagnostics developer said that it brought in $1.2 million in licensing fees for the three-month period ended Dec. 31, compared to $338,000 for the fourth quarter of 2008. The company reported no product revenues for either period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.